Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Intraprocedural Cortisol Measurement on ACTH-stimulated Adrenal Vein Sampling in Primary Aldosteronism.
Kometani M, Yoneda T, Karashima S, Takeda Y, Tsuiki M, Yasoda A, Kurihara I, Wada N, Katabami T, Sone M, Ichijo T, Tamura K, Ogawa Y, Kobayashi H, Okamura S, Inagaki N, Kawashima J, Fujita M, Oki K, Matsuda Y, Tanabe A, Naruse M. Kometani M, et al. Among authors: oki k. J Endocr Soc. 2022 Jul 26;6(9):bvac104. doi: 10.1210/jendso/bvac104. eCollection 2022 Sep 1. J Endocr Soc. 2022. PMID: 35928241 Free PMC article.
Immunohistochemistry of aldosterone synthase leads the way to the pathogenesis of primary aldosteronism.
Nishimoto K, Koga M, Seki T, Oki K, Gomez-Sanchez EP, Gomez-Sanchez CE, Naruse M, Sakaguchi T, Morita S, Kosaka T, Oya M, Ogishima T, Yasuda M, Suematsu M, Kabe Y, Omura M, Nishikawa T, Mukai K. Nishimoto K, et al. Among authors: oki k. Mol Cell Endocrinol. 2017 Feb 5;441:124-133. doi: 10.1016/j.mce.2016.10.014. Epub 2016 Oct 14. Mol Cell Endocrinol. 2017. PMID: 27751767 Free PMC article. Review.
Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Oki K, Kamemura K, Tanabe A, Naruse M; JPAS/JRAS study group. Nakamaru R, et al. Among authors: oki k. Hypertension. 2021 Feb;77(2):537-545. doi: 10.1161/HYPERTENSIONAHA.120.16449. Epub 2020 Dec 28. Hypertension. 2021. PMID: 33356395
Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
Nakamaru R, Yamamoto K, Akasaka H, Rakugi H, Kurihara I, Yoneda T, Ichijo T, Katabami T, Tsuiki M, Wada N, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Fujita M, Watanabe M, Kamemura K, Okamura S, Tanabe A, Naruse M; JPAS/JRAS Study Group. Nakamaru R, et al. Sci Rep. 2021 Mar 25;11(1):6925. doi: 10.1038/s41598-021-86290-3. Sci Rep. 2021. PMID: 33767283 Free PMC article.
Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.
Haze T, Hirawa N, Yano Y, Tamura K, Kurihara I, Kobayashi H, Tsuiki M, Ichijo T, Wada N, Katabami T, Yamamoto K, Oki K, Inagaki N, Okamura S, Kai T, Izawa S, Yamada M, Chiba Y, Tanabe A, Naruse M. Haze T, et al. Among authors: oki k. Atherosclerosis. 2021 May;324:84-90. doi: 10.1016/j.atherosclerosis.2021.03.033. Epub 2021 Mar 29. Atherosclerosis. 2021. PMID: 33831673
Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?
Okamoto K, Ohno Y, Sone M, Inagaki N, Ichijo T, Yoneda T, Tsuiki M, Wada N, Oki K, Tamura K, Kobayashi H, Izawa S, Tanabe A, Naruse M. Okamoto K, et al. Among authors: oki k. Front Endocrinol (Lausanne). 2021 Apr 12;12:645395. doi: 10.3389/fendo.2021.645395. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33912136 Free PMC article.
Renal Injuries in Primary Aldosteronism: Quantitative Histopathological Analysis of 19 Patients With Primary Adosteronism.
Ogata H, Yamazaki Y, Tezuka Y, Gao X, Omata K, Ono Y, Kawasaki Y, Tanaka T, Nagano H, Wada N, Oki Y, Ikeya A, Oki K, Takeda Y, Kometani M, Kageyama K, Terui K, Gomez-Sanchez CE, Liu S, Morimoto R, Joh K, Sato H, Miyazaki M, Ito A, Arai Y, Nakamura Y, Ito S, Satoh F, Sasano H. Ogata H, et al. Among authors: oki k, oki y. Hypertension. 2021 Aug;78(2):411-421. doi: 10.1161/HYPERTENSIONAHA.121.17436. Epub 2021 Jun 14. Hypertension. 2021. PMID: 34120452 Free PMC article.
Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
Saito K, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Kawashima J, Inagaki N, Yamamoto K, Yamada M, Kamemura K, Fujii Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; Japan Primary Aldosteronism Study/Japan Rare Intractable Adrenal Diseases Study Group. Saito K, et al. Among authors: oki k. J Hypertens. 2021 Nov 1;39(11):2325-2332. doi: 10.1097/HJH.0000000000002924. J Hypertens. 2021. PMID: 34224538
Association of cardiovascular disease risk and changes in renin levels by mineralocorticoid receptor antagonists in patients with primary aldosteronism.
Nomura M, Kurihara I, Itoh H, Ichijo T, Katabami T, Tsuiki M, Wada N, Yoneda T, Sone M, Oki K, Yamada T, Kobayashi H, Tamura K, Ogawa Y, Inagaki N, Yamamoto K, Otsuki M, Yabe D, Izawa S, Takahashi Y, Suzuki T, Yasoda A, Tanabe A, Naruse M; JPAS/JRAS Study Group. Nomura M, et al. Among authors: oki k. Hypertens Res. 2022 Sep;45(9):1476-1485. doi: 10.1038/s41440-022-00960-x. Epub 2022 Jun 28. Hypertens Res. 2022. PMID: 35764671
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Among authors: oki k. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
400 results